This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ProPhase Labs Inc (PRPH)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 2.93M 1.64M 572.00K 5.54M
Receivables 5.84M 5.32M 5.41M 3.22M
Inventories 3.29M 2.52M 2.05M 2.69M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 13.46M 11.28M 10.72M 13.20M
Property, Plant & Equipment, Gross 6.94M 6.63M 6.22M 5.92M
Accumulated Depreciation & Depletion 4.34M 4.06M 3.86M 3.61M
Property, Plant & Equipment, Net 2.60M 2.56M 2.37M 2.31M
Intangibles 0.00 3.58M 3.58M 3.58M
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 2.60M 6.14M 5.94M 5.88M
Liabilities & Shareholder Equity
Total Assets 16.06M 17.42M 16.66M 19.08M
Accounts Payable 667.00K 1.01M 1.30M 885.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 889.00K 766.00K 854.00K 485.00K
Total Current Liabilities 5.24M 4.62M 4.91M 7.85M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 100.00K 200.00K 300.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 100.00K 200.00K 300.00K 0.00
Total Liabilities 5.34M 4.82M 5.21M 7.85M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 10.72M 12.60M 11.45M 11.23M
Common Par 13.00K 11.00K 11.00K 10.00K
Additional Paid In Capital 54.66M 43.61M 42.87M 41.55M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -13.22M -5.38M -5.79M -4.70M
Treasury Stock -30.74M -25.64M -25.64M -25.64M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 10.72M 12.60M 11.45M 11.23M
Total Equity 10.72M 12.60M 11.45M 11.23M
Total Liabilities & Stock Equity 16.06M 17.42M 16.66M 19.08M
Total Common Shares Outstanding 15.89M 16.10M 15.72M 14.83M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 9.23M 5.34M 5.34M 5.34M
Basic Weighted Shares Outstanding 16.77M 15.84M 14.84M 14.82M
Diluted Weighted Shares Outstanding 16.77M 16.28M 14.84M 14.82M
Number of Employees 54 50 50 49
Number of Part-Time Employees 1 0 0 0

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PRPH ProPhase Labs Inc

Chart of PRPH

Analysts Ratings for PRPH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell

PRPH Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs